43
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A healthy gastrointestinal microbiome is dependent on dietary diversity

      review-article
      1 , , 2
      Molecular Metabolism
      Elsevier
      Microbiome, Microbiota, Gastrointestinal, Dietary diversity, Agrobiodiversity, Microbiota richness, FXR, farnesoid X receptor, FODMAP, fermentable oligo-, di-, monosaccharides and polyols, FDA, Food and Drug Administration, GI, gastrointestinal, GIMM, GI microbiome modulator, GLP-I, glucagon-like peptide-1, GLUT, glucose transporter, HMP, Human Microbiome Project, MCFA, medium chain fatty acids, MetaHIT, Metagenomics project of the Human Intestinal Tract, NIH, National Institutes of Health, PYY, peptide YY, RYGB, Roux-en-Y gastric bypass, SCFA, short chain fatty acid, SGLTs, sodium–glucose cotransporter, TMA, trimethylamine, TMAO, trimethylamine-N-oxide, VSG, vertical sleeve gastrectomy

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Like all healthy ecosystems, richness of microbiota species characterizes the GI microbiome in healthy individuals. Conversely, a loss in species diversity is a common finding in several disease states. This biome is flooded with energy in the form of undigested and partially digested foods, and in some cases drugs and dietary supplements. Each microbiotic species in the biome transforms that energy into new molecules, which may signal messages to physiological systems of the host.

          Scope of review

          Dietary choices select substrates for species, providing a competitive advantage over other GI microbiota. The more diverse the diet, the more diverse the microbiome and the more adaptable it will be to perturbations. Unfortunately, dietary diversity has been lost during the past 50 years and dietary choices that exclude food products from animals or plants will narrow the GI microbiome further.

          Major conclusion

          Additional research into expanding gut microbial richness by dietary diversity is likely to expand concepts in healthy nutrition, stimulate discovery of new diagnostics, and open up novel therapeutic possibilities.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: not found

          Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice.

          Obesity is a highly heritable disease driven by complex interactions between genetic and environmental factors. Human genome-wide association studies (GWAS) have identified a number of loci contributing to obesity; however, a major limitation of these studies is the inability to assess environmental interactions common to obesity. Using a systems genetics approach, we measured obesity traits, global gene expression, and gut microbiota composition in response to a high-fat/high-sucrose (HF/HS) diet of more than 100 inbred strains of mice. Here we show that HF/HS feeding promotes robust, strain-specific changes in obesity that are not accounted for by food intake and provide evidence for a genetically determined set point for obesity. GWAS analysis identified 11 genome-wide significant loci associated with obesity traits, several of which overlap with loci identified in human studies. We also show strong relationships between genotype and gut microbiota plasticity during HF/HS feeding and identify gut microbial phylotypes associated with obesity. Copyright © 2013 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The vocabulary of microbiome research: a proposal

            ᅟ The advancement of DNA/RNA, proteins, and metabolite analytical platforms, combined with increased computing technologies, has transformed the field of microbial community analysis. This transformation is evident by the exponential increase in the number of publications describing the composition and structure, and sometimes function, of the microbial communities inhabiting the human body. This rapid evolution of the field has been accompanied by confusion in the vocabulary used to describe different aspects of these communities and their environments. The misuse of terms such as microbiome, microbiota, metabolomic, and metagenome and metagenomics among others has contributed to misunderstanding of many study results by the scientific community and the general public alike. A few review articles have previously defined those terms, but mainly as sidebars, and no clear definitions or use cases have been published. In this editorial, we aim to propose clear definitions of each of these terms, which we would implore scientists in the field to adopt and perfect.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Ghrelin octanoylation mediated by an orphan lipid transferase.

              The peptide hormone ghrelin is the only known protein modified with an O-linked octanoyl side group, which occurs on its third serine residue. This modification is crucial for ghrelin's physiological effects including regulation of feeding, adiposity, and insulin secretion. Despite the crucial role for octanoylation in the physiology of ghrelin, the lipid transferase that mediates this novel modification has remained unknown. Here we report the identification and characterization of human GOAT, the ghrelin O-acyl transferase. GOAT is a conserved orphan membrane-bound O-acyl transferase (MBOAT) that specifically octanoylates serine-3 of the ghrelin peptide. Transcripts for both GOAT and ghrelin occur predominantly in stomach and pancreas. GOAT is conserved across vertebrates, and genetic disruption of the GOAT gene in mice leads to complete absence of acylated ghrelin in circulation. The occurrence of ghrelin and GOAT in stomach and pancreas tissues demonstrates the relevance of GOAT in the acylation of ghrelin and further implicates acylated ghrelin in pancreatic function.
                Bookmark

                Author and article information

                Contributors
                Journal
                Mol Metab
                Mol Metab
                Molecular Metabolism
                Elsevier
                2212-8778
                05 March 2016
                May 2016
                05 March 2016
                : 5
                : 5
                : 317-320
                Affiliations
                [1 ]MicroBiome Therapeutics, 1316 Jefferson Avenue, New Orleans, LA 70115, USA
                [2 ]Pennington Biomedical Research Center, Louisiana State University System, 6400 Perkins Road, Baton Rouge, LA 70808, USA
                Author notes
                []Corresponding author. Tel.: +1 317 997 2335. mheiman@ 123456mbiome.com
                Article
                S2212-8778(16)00038-7
                10.1016/j.molmet.2016.02.005
                4837298
                27110483
                fcb858e8-c19a-4c9b-9a74-89f0b3ca1925
                © 2016 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 19 February 2016
                : 29 February 2016
                Categories
                Review

                microbiome,microbiota,gastrointestinal,dietary diversity,agrobiodiversity,microbiota richness,fxr, farnesoid x receptor,fodmap, fermentable oligo-, di-, monosaccharides and polyols,fda, food and drug administration,gi, gastrointestinal,gimm, gi microbiome modulator,glp-i, glucagon-like peptide-1,glut, glucose transporter,hmp, human microbiome project,mcfa, medium chain fatty acids,metahit, metagenomics project of the human intestinal tract,nih, national institutes of health,pyy, peptide yy,rygb, roux-en-y gastric bypass,scfa, short chain fatty acid,sglts, sodium–glucose cotransporter,tma, trimethylamine,tmao, trimethylamine-n-oxide,vsg, vertical sleeve gastrectomy

                Comments

                Comment on this article